These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30141571)

  • 61. American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection.
    Jacobson IM; Lim JK; Fried MW
    Gastroenterology; 2017 May; 152(6):1578-1587. PubMed ID: 28344022
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatitis C virus infection in dialysis and clinical nephrology.
    Fabrizi F; Locatelli F
    Int J Artif Organs; 1995 May; 18(5):235-44. PubMed ID: 8567099
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of hepatitis C virus infection and malnutrition-inflammation complex syndrome in maintenance hemodialysis patients.
    Tsai HB; Chen PC; Liu CH; Hung PH; Chen MT; Chiang CK; Kao JH; Hung KY
    Nephrol Dial Transplant; 2012 Mar; 27(3):1176-83. PubMed ID: 21896499
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Treatment of hepatitis C in patients on renal replacement therapy].
    Tornai I; Mátyus J
    Orv Hetil; 2007 Mar; 148(11):489-94. PubMed ID: 17350920
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect and Safety of Daclatasvir-Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b -Infected Patients on Hemodialysis.
    Miyazaki R; Miyagi K
    Ther Apher Dial; 2016 Oct; 20(5):462-467. PubMed ID: 27098678
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatitis C virus and nonliver solid organ transplantation.
    Carbone M; Mutimer D; Neuberger J
    Transplantation; 2013 Mar; 95(6):779-86. PubMed ID: 23172130
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevention of hepatitis C virus infection and liver cancer.
    Lim EJ; Torresi J
    Recent Results Cancer Res; 2014; 193():113-33. PubMed ID: 24008296
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased systemic sST2 in patients with end stage renal disease contributes to milder liver damage during HCV infection.
    Lukic R; Cupic M; Gajovic N; Jurisevic M; Mijailovic Z; Davidovic B; Kujundzic B; Joksimovic B; Arsenijevic N; Jovanovic I
    J Infect Dev Ctries; 2020 May; 14(5):519-526. PubMed ID: 32525839
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatitis C virus infection in dialysis patients.
    Sułowicz W; Radziszewski A; Chowaniec E
    Hemodial Int; 2007 Jul; 11(3):286-95. PubMed ID: 17576291
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hearing assessment in Egyptian children with chronic renal failure on regular hemodialysis and renal transplantation children.
    Fadel FI; Yamamah GAN; Hasanin RM; Mostafa EA; Abdalgeleel SA; Salah MM; Galal REE; Abdel Mawla MA
    Ther Apher Dial; 2022 Oct; 26(5):960-968. PubMed ID: 34951736
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The natural history of hepatitis C virus infection.
    Kenny-Walsh E
    Clin Liver Dis; 2001 Nov; 5(4):969-77. PubMed ID: 11685804
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 2011 Japanese Society for Dialysis Therapy guidelines for the treatment of hepatitis C virus infection in dialysis patients.
    Akiba T; Hora K; Imawari M; Sato C; Tanaka E; Izumi N; Harada T; Ando R; Kikuchi K; Tomo T; Hirakata H; Akizawa T
    Ther Apher Dial; 2012 Aug; 16(4):289-310. PubMed ID: 22817117
    [No Abstract]   [Full Text] [Related]  

  • 73. Hepatitis C infection in patients with chronic renal failure receiving conservative therapy.
    Ilçöl B; Ozener C; Avşar M; Ilçol Y; Lawrence R; Ozer A; Cirakoğlu B; Akoğlu E
    Nephrol Dial Transplant; 1997 Mar; 12(3):626. PubMed ID: 9075165
    [No Abstract]   [Full Text] [Related]  

  • 74. Care of Patients Following Cure of Hepatitis C Virus Infection.
    Terrault NA
    Gastroenterol Hepatol (N Y); 2018 Nov; 14(11):629-634. PubMed ID: 30538603
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hepatitis C and kidney disease: An overview and approach to management.
    Azmi AN; Tan SS; Mohamed R
    World J Hepatol; 2015 Jan; 7(1):78-92. PubMed ID: 25624999
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Noninvasive Tests to Detect Advanced Fibrosis in Patients With Hepatitis C and End-Stage Renal Disease: Ready for Primetime?
    Debnath P; Rathi P
    Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1989. PubMed ID: 33248079
    [No Abstract]   [Full Text] [Related]  

  • 77. New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat.
    Sawinski D; Forde KA; Wyatt CM
    Am J Kidney Dis; 2018 Jul; 72(1):7-9. PubMed ID: 29580661
    [No Abstract]   [Full Text] [Related]  

  • 78. Treatment of chronic hepatitis C virus infection in patients with end-stage renal disease on hemodialysis.
    Mittal Y; Liapakis A; Lim JK
    Clin Liver Dis (Hoboken); 2016 Sep; 8(3):76-78. PubMed ID: 31041068
    [No Abstract]   [Full Text] [Related]  

  • 79. The hepatitis virus infection and renal replacement therapies: What is the relation?
    Pustake M; Giri P; Ganiyani MA; Purwar S
    J Family Med Prim Care; 2022 Nov; 11(11):7497-7498. PubMed ID: 36993061
    [No Abstract]   [Full Text] [Related]  

  • 80. Safety and efficacy of grazoprevir/elbasvir in the treatment of acute hepatitis C in hemodialysis patients.
    Ji Q; Chu X; Zhou Y; Liu X; Zhao W; Ye W
    J Med Virol; 2022 Feb; 94(2):675-682. PubMed ID: 34599755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.